• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Trial of chlorhexidine gluconate for fungal corneal ulcers.

作者信息

Rahman M R, Minassian D C, Srinivasan M, Martin M J, Johnson G J

机构信息

Department of Preventive Ophthalmology, St. George's Hospital, London, England.

出版信息

Ophthalmic Epidemiol. 1997 Sep;4(3):141-9. doi: 10.3109/09286589709115721.

DOI:10.3109/09286589709115721
PMID:9377282
Abstract

AIMS

Suppurative corneal ulcers due to filamentous fungi are a serious and intractable problem in many tropical developing countries. In vitro studies and a small pilot study have shown that chlorhexidine gluconate is effective. The aim was to establish the optimum concentration which would be appropriate to use in a larger randomized clinical trial.

METHODS

A masked randomized clinical trial of three concentrations of chlorhexidine compared with natamycin 5% was carried out in consecutive patients with established corneal ulcers shown by microscopy to contain fungal hyphae and later proven to be culture positive. Topical treatments were applied 1/2-hourly to 2-hourly for up to 5 days, with reduced frequency thereafter, and all patients were re-assessed at 21 days.

RESULTS

Of 60 patients entered in the trial, 2 were lost to follow-up, and 12 were classified as 'severe' with little prospect of recovery. At 5 days the response was related to the concentration of chlorhexidine, with 0.2% giving the best results. Compared with the response to natamycin as the referent, the relative efficacy was 1.17 with chlorhexidine 0.05%, 1.43 with 0.1%, and 2.00 with 0.2%. The superiority of 0.2% chlorhexidine over natamycin was statistically significant (relative efficacy 2.20, p = 0.043) in patients not having had prior antifungal treatment.

CONCLUSIONS

This preliminary study justifies further trials of chlorhexidine as a primary treatment for fungal corneal ulcers in circumstances where specific antifungal agents are not available.

摘要

相似文献

1
Trial of chlorhexidine gluconate for fungal corneal ulcers.
Ophthalmic Epidemiol. 1997 Sep;4(3):141-9. doi: 10.3109/09286589709115721.
2
Randomised trial of 0.2% chlorhexidine gluconate and 2.5% natamycin for fungal keratitis in Bangladesh.孟加拉国0.2%葡萄糖酸氯己定和2.5%那他霉素治疗真菌性角膜炎的随机试验
Br J Ophthalmol. 1998 Aug;82(8):919-25. doi: 10.1136/bjo.82.8.919.
3
Topical Chlorhexidine 0.2% versus Topical Natamycin 5% for the Treatment of Fungal Keratitis in Nepal: A Randomized Controlled Noninferiority Trial.尼泊尔局部应用 0.2%洗必泰与 5%那他霉素治疗真菌性角膜炎的随机对照非劣效性试验。
Ophthalmology. 2022 May;129(5):530-541. doi: 10.1016/j.ophtha.2021.12.004. Epub 2021 Dec 9.
4
Comparison of natamycin and voriconazole for the treatment of fungal keratitis.那他霉素与伏立康唑治疗真菌性角膜炎的比较。
Arch Ophthalmol. 2010 Jun;128(6):672-8. doi: 10.1001/archophthalmol.2010.102.
5
Voriconazole versus natamycin as primary treatment in fungal corneal ulcers.伏立康唑与那他霉素治疗真菌性角膜溃疡的对比研究。
Clin Exp Ophthalmol. 2011 Jul;39(5):434-40. doi: 10.1111/j.1442-9071.2010.02473.x. Epub 2011 Jun 28.
6
Chlorhexidine gluconate 0.02% as adjunct to primary treatment for corneal bacterial ulcers.0.02%葡萄糖酸洗必泰作为角膜细菌性溃疡初始治疗的辅助用药。
Isr Med Assoc J. 2009 Nov;11(11):664-8.
7
Adjunctive Oral Voriconazole Treatment of Fusarium Keratitis: A Secondary Analysis From the Mycotic Ulcer Treatment Trial II.伏立康唑口服辅助治疗镰刀菌角膜炎:真菌性溃疡治疗试验II的二次分析
JAMA Ophthalmol. 2017 Jun 1;135(6):520-525. doi: 10.1001/jamaophthalmol.2017.0616.
8
Vision-Related Quality-of-Life Outcomes in the Mycotic Ulcer Treatment Trial I: A Randomized Clinical Trial.真菌性溃疡治疗试验I中与视力相关的生活质量结果:一项随机临床试验。
JAMA Ophthalmol. 2015 Jun;133(6):642-6. doi: 10.1001/jamaophthalmol.2015.0319.
9
Effect of Oral Voriconazole on Fungal Keratitis in the Mycotic Ulcer Treatment Trial II (MUTT II): A Randomized Clinical Trial.口服伏立康唑在真菌性溃疡治疗试验II(MUTT II)中对真菌性角膜炎的疗效:一项随机临床试验。
JAMA Ophthalmol. 2016 Dec 1;134(12):1365-1372. doi: 10.1001/jamaophthalmol.2016.4096.
10
Re-appraisal of topical 1% voriconazole and 5% natamycin in the treatment of fungal keratitis in a randomised trial.在一项随机试验中对局部用1%伏立康唑和5%那他霉素治疗真菌性角膜炎的重新评估。
Br J Ophthalmol. 2015 Sep;99(9):1190-5. doi: 10.1136/bjophthalmol-2014-306485. Epub 2015 Mar 4.

引用本文的文献

1
Pathogenesis and treatment strategies for infectious keratitis: Exploring antibiotics, antimicrobial peptides, nanotechnology, and emerging therapies.感染性角膜炎的发病机制与治疗策略:探索抗生素、抗菌肽、纳米技术及新兴疗法
J Pharm Anal. 2025 Sep;15(9):101250. doi: 10.1016/j.jpha.2025.101250. Epub 2025 Feb 28.
2
Randomised controlled trial of topical combination therapy chlorhexidine 0.2% and natamycin 5% versus topical natamycin 5% alone for fungal keratitis in East Africa: study protocol.东非地区0.2%洗必泰与5%那他霉素局部联合治疗对比单用5%那他霉素治疗真菌性角膜炎的随机对照试验:研究方案
Wellcome Open Res. 2025 Mar 28;10:165. doi: 10.12688/wellcomeopenres.21390.1. eCollection 2025.
3
Local Ugandan Production of Stable 0.2% Chlorhexidine Eye Drops.
本地化生产 0.2%氯己定滴眼液。
Transl Vis Sci Technol. 2023 Jan 3;12(1):27. doi: 10.1167/tvst.12.1.27.
4
Management of Filamentous Fungal Keratitis: A Pragmatic Approach.丝状真菌性角膜炎的管理:一种实用方法
J Fungi (Basel). 2022 Oct 11;8(10):1067. doi: 10.3390/jof8101067.
5
Topical Chlorhexidine 0.2% versus Topical Natamycin 5% for the Treatment of Fungal Keratitis in Nepal: A Randomized Controlled Noninferiority Trial.尼泊尔局部应用 0.2%洗必泰与 5%那他霉素治疗真菌性角膜炎的随机对照非劣效性试验。
Ophthalmology. 2022 May;129(5):530-541. doi: 10.1016/j.ophtha.2021.12.004. Epub 2021 Dec 9.
6
Keratitis-Review of Current Treatment Possibilities.角膜炎——当前治疗方法综述
J Clin Med. 2021 Nov 23;10(23):5468. doi: 10.3390/jcm10235468.
7
Fungal keratitis: Mechanisms of infection and management strategies.真菌性角膜炎:感染机制与治疗策略。
Surv Ophthalmol. 2022 May-Jun;67(3):758-769. doi: 10.1016/j.survophthal.2021.08.002. Epub 2021 Aug 20.
8
Chlorhexidine gluconate 0.2% as a treatment for recalcitrant fungal keratitis in Uganda: a pilot study.0.2%葡萄糖酸洗必泰治疗乌干达顽固性真菌性角膜炎的一项初步研究。
BMJ Open Ophthalmol. 2021 Jul 5;6(1):e000698. doi: 10.1136/bmjophth-2020-000698. eCollection 2021.
9
Mycotic Keratitis-A Global Threat from the Filamentous Fungi.真菌性角膜炎——来自丝状真菌的全球威胁。
J Fungi (Basel). 2021 Apr 3;7(4):273. doi: 10.3390/jof7040273.
10
Chlorhexidine for the Treatment of Keratitis: A Case Series and Mini Review.洗必泰治疗角膜炎:病例系列及小型综述
J Fungi (Basel). 2021 Mar 29;7(4):255. doi: 10.3390/jof7040255.